User:Mr. Ibrahem/Doravirine/lamivudine/tenofovir

Doravirine/lamivudine/tenofovir, sold under the brand name Delstrigo, is a combination medication used to treat HIV/AIDS. It may be used as an initial treatment. It may be the only medication a person requires. It is taken by mouth.

Common side effects include dizziness, nausea, and abnormal dreams. Other side effects may include kidney problems, osteoporosis, and immune reconstitution syndrome. Safety in pregnancy is unclear. It contains doravirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), and lamivudine and tenofovir disoproxil, both nucleoside analogue reverse transcriptase inhibitors.

The combination was approved for medical use in the United States and Europe in 2018. In the United Kingdom a month of medication costs the NHS about £580 as of 2021. In Canada this amount is about 865 CAD while in the United States it is about 2,260 USD.